- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
RhoGDI2 up-regulates P-glycoprotein expression via Rac1 in gastric cancer cells ; volume:15 ; number:1 ; day:15 ; month:4 ; year:2015 ; pages:1-7 ; date:12.2015
Cancer cell international ; 15, Heft 1 (15.4.2015), 1-7, 12.2015
- Creator
-
Zheng, Zhong
Liu, Bingya
Wu, Xiaohua
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-015-0190-4
- URN
-
urn:nbn:de:101:1-2021082809404806215975
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zheng, Zhong
- Liu, Bingya
- Wu, Xiaohua
- SpringerLink (Online service)
Other Objects (12)
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
P-glycoprotein transporter in drug development
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Decreased blood-brain barrier P-glycoprotein function with aging
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Funktionelle Komplementierung des cystic fibrosis transmembrane conductance regulator (CFTR) durch Überexpression des membranständigen Transportproteins P-Glycoprotein : Untersuchung des ATP-Transportes durch P-Glycoprotein
C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance
Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein
A PET microdosing study with the P-glycoprotein inhibitor tariquidar
Streptococcus agalactiae disrupts P-glycoprotein function in brain endothelial cells
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
P-glycoprotein transporter in drug development
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Decreased blood-brain barrier P-glycoprotein function with aging
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Funktionelle Komplementierung des cystic fibrosis transmembrane conductance regulator (CFTR) durch Überexpression des membranständigen Transportproteins P-Glycoprotein : Untersuchung des ATP-Transportes durch P-Glycoprotein
C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance
Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein
A PET microdosing study with the P-glycoprotein inhibitor tariquidar
Streptococcus agalactiae disrupts P-glycoprotein function in brain endothelial cells
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
P-glycoprotein transporter in drug development
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Decreased blood-brain barrier P-glycoprotein function with aging
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Funktionelle Komplementierung des cystic fibrosis transmembrane conductance regulator (CFTR) durch Überexpression des membranständigen Transportproteins P-Glycoprotein : Untersuchung des ATP-Transportes durch P-Glycoprotein
C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance
Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein
A PET microdosing study with the P-glycoprotein inhibitor tariquidar